Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2025-12-24 @ 1:58 PM
NCT ID:
NCT02918695
Eligibility Criteria:
Inclusion Criteria:
* newly diagnosed multiple myeloma
* age =\> 70 years
* no previous anti-myeloma treatment except for local radiotherapy or short course (max 4 days) of high-dose dexamethasone
* signed informed consent
* patients included in an interventional therapeutic trial are eligible
Exclusion Criteria:
* previous systemic anti-myeloma treatment
* severe mental or cognitive disorder precluding geriatric assessment
* patient refusal to sign informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT02918695
Study Brief:
Protocol Section:
NCT02918695